Результати пошуку - Gil Redelman‐Sidi
- Показ 1 - 13 результатів із 13
-
1
Could BCG be used to protect against COVID-19? за авторством Gil Redelman‐Sidi
Опубліковано 2020Revisão -
2
BCG in Bladder Cancer Immunotherapy за авторством Song Jiang, Gil Redelman‐Sidi
Опубліковано 2022Revisão -
3
Rapidly Growing Mycobacteria Infection in Patients with Cancer за авторством Gil Redelman‐Sidi, Kent A. Sepkowitz
Опубліковано 2010Artigo -
4
Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy за авторством Tommaso Morelli, Kohei Fujita, Gil Redelman‐Sidi, Paul Elkington
Опубліковано 2021Revisão -
5
-
6
-
7
-
8
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Immune ch... за авторством Gil Redelman‐Sidi, Olivier Michielin, Carlos Cervera, Camillo Ribi, José María Aguado, Mario Fernández‐Ruiz, Oriol Manuel
Опубліковано 2018Revisão -
9
Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid Cancer за авторством Tilly Varughese, Ying Taur, Nina Cohen, M. Lia Palomba, Susan K. Seo, Tobias M. Hohl, Gil Redelman‐Sidi
Опубліковано 2018Artigo -
10
The Spectrum of Serious Infections Among Patients Receiving Immune Checkpoint Blockade for the Treatment of Melanoma за авторством María del Carmen López Castillo, Fabián Andrés Rosas Romero, Esther Argüello, Chrisann Kyi, Michael A. Postow, Gil Redelman‐Sidi
Опубліковано 2016Artigo -
11
The Canonical Wnt Pathway Drives Macropinocytosis in Cancer за авторством Gil Redelman‐Sidi, Anna Binyamin, Isabella Gaeta, Wilhelm Palm, Craig B. Thompson, Paul B. Romesser, Scott W. Lowe, Mukta Bagul, John G. Doench, David E. Root, Michael S. Glickman
Опубліковано 2018Artigo -
12
Determinants of Severity in Cancer Patients with COVID-19 Illness за авторством Elizabeth Robilotti, N. Esther Babady, Peter A. Mead, Thierry Rolling, Rocío Pérez-Johnston, Marilia Bernardes, Yael Bogler, Mario Caldararo, C. Ortiz, Michael S. Glickman, Alexa Joanow, Anna Kaltsas, Yeon Joo Lee, Anabella Lucca Bianchi, Amanda Mariano, Sejal Morjaria, Tamara Nawar, Genovefa A. Papanicolaou, Jacqueline Predmore, Gil Redelman‐Sidi, Elizabeth Schmidt, Susan K. Seo, Kent A. Sepkowitz, Monika K. Shah, Jedd D. Wolchok, Tobias M. Hohl, Ying Taur, Mini Kamboj
Опубліковано 2020Pré-impressão -
13
Determinants of COVID-19 disease severity in patients with cancer за авторством Elizabeth Robilotti, N. Esther Babady, Peter A. Mead, Thierry Rolling, Rocío Pérez-Johnston, Marilia Bernardes, Yael Bogler, Mario Caldararo, Cesar J. Figueroa, Michael S. Glickman, Alexa Joanow, Anna Kaltsas, Yeon Joo Lee, Anabella Lucca Bianchi, Amanda Mariano, Sejal Morjaria, Tamara Nawar, Genovefa A. Papanicolaou, Jacqueline Predmore, Gil Redelman‐Sidi, Elizabeth Schmidt, Susan K. Seo, Kent A. Sepkowitz, Monika K. Shah, Jedd D. Wolchok, Tobias M. Hohl, Ying Taur, Mini Kamboj
Опубліковано 2020Artigo
Інструменти для пошуку:
Пов'язані теми
Medicine
Cancer
Internal medicine
Immunology
Biology
Cancer research
Immune system
Immunotherapy
Cancer immunotherapy
Cell biology
Coronavirus disease 2019 (COVID-19)
Disease
Genetics
Infectious disease (medical specialty)
Pathology
Receptor
Tuberculosis
Bladder cancer
Cancer cell
Carcinogenesis
Cell
Endocytosis
Environmental health
Immunity
Intensive care medicine
Lung cancer
Mycobacterium tuberculosis
Oncology
Pinocytosis
Population